Target intelligence / Profile preview

Golgin subfamily A member 1 (GOLGA1)

Target
GOLGA1
Molecular classification
Other (Golgi structural protein), Golgin protein family
01

Overview

Golgin subfamily A member 1 (GOLGA1), also known as golgin-97, is a member of the golgin family of proteins localized to the Golgi apparatus, where it plays a fundamental role in vesicular trafficking, specifically in endosome-to-Golgi and intra-Golgi transport. It is important for maintaining Golgi structure, reorganization during mitosis, and is involved in the selective transport of vesicles, including those containing E-cadherin. GOLGA1 has associations with several rare genetic diseases (e.g., Robinow syndrome, spastic paraplegia), and autoantibody responses against this protein are seen in Sjögren's syndrome. It serves more as an intracellular trafficking and structural protein than a canonical therapeutic target like a receptor or enzyme. Although involved in important cellular functions, GOLGA1 is not currently considered a direct therapeutic target (e.g., receptor, enzyme, transporter), nor are there drugs approved or in development that directly interact with it as a mechanism of action. It can be relevant as a potential biomarker for autoimmunity (Sjogren’s syndrome), but is not used in clinical practice as such.

Other names
Golgin-97Golgin A1GOLGA1MGC33154Golgi autoantigengap junction protein, alpha 4, 37kDGolgin subfamily a, 1
02

Mechanism of action

Not applicable; no drugs directly targeting GOLGA1 are reported

03

Biological functions

Vesicular trafficking at the Golgi apparatusEndosome-to-Golgi traffickingRegulation of E-cadherin transport from trans-Golgi networkGolgi structure and dynamics, especially during mitosisPossible role in viral morphogenesis (poxvirus maturation)
04

Disease associations

Robinow syndrome, autosomal dominant 1Spastic paraplegia 50, autosomal recessiveAssociation with Sjögren's syndromePossible relevance in infection (orthopoxvirus)
05

Safety considerations

No notable safety concerns or therapeutic challenges reported; not a validated drug target
06

Interacting drugs

None reported in current literature or drug databases specific for this protein
07

Biomarkers

No established biomarker use for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Golgin subfamily A member 1 (GOLGA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Golgin subfamily A member 1 (GOLGA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call